A service of StreetInsider.com
Ticker Symbol

Most Popular

AAPL 143.65
GOOG 905.96
MSFT 68.46
BAC 23.34
FB 150.25

Recently Added

SNAP 22.55
UAA 21.49
LSTR 85.45
UDOW 112.93
DXC 75.34

Gaining Speed

UAA 21.49
LSTR 85.45
SNAP 22.55
UDOW 112.93
TQQQ 95.33

ZIOPHARM Oncology (ZIOP) Reports Palifosfamide Hits PFS Events in Phase 3

ZIOPHARM Oncology, Inc. (Nasdaq: ZIOP) announced today that the Phase 3 (PICASSO 3) trial of palifosfamide (ZIO-201) in first-line metastatic soft tissue sarcoma has reached its target number of progression-free survival (PFS) events. PICASSO 3 is an international, randomized, double-blind, placebo-controlled trial whose primary endpoint is PFS....

Read More




Get Alerted When News Hits On This Stock - FREE!